Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Justice Department to ask Supreme Court to intervene in abortion pill case

WASHINGTON — Attorney General Merrick Garland said the Biden administration will ask the U.S. Supreme Court to protect the availability of a widely used abortion pill after a federal appeals court cleared the way for new restrictions to take effect Friday.

Tribune News Service

Justice Department will ask the Supreme Court to restore full access to abortion pill

The Justice Department is seeking emergency relief from the U.S. Supreme Court in a Texas case involving limited access to the abortion drug mifepristone.

WEKU

How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own

Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Optimal Stocks to Own in April... At a Value

Although inflation has shown signs of easing, it remains elevated. Therefore, the possibility of further rate hikes remains. As fears of a recession rise, investors may consider buying fundamentally strong stocks NetScout Systems (NTCT), Central Puerto (CEPU), and Vanda Pharmaceuticals (VNDA), trading at discounts to their peers. Keep reading….

StockNews.com

Appeals court okays abortion pill limits

Court upheld part of a Texas judge's ruling halting FDA decision allowing mifepristone to be distributed by mail

Salon

Appeals court allows limited access to abortion pill

A federal appeals court partly granted the Biden administration’s request to put on hold a Texas court ruling overturning FDA approval of the abortion pill, but allowed restrictions that were lifted since 2016 to be reinstated.

Tribune News Service

Leaker of Ukraine Intelligence Was Reportedly a Gun Enthusiast Trying To Impress His Discord Friends

Plus: New developments in the Texas abortion drug ruling, fallout from the Riley Gaines event at SFSU, and more...

Reason

Read news from The Economist, FT, and more,
with one subscription

Abortion’s new battleground: Mifepristone’s effect on women’s mental health

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

Los Angeles Times

Abortion drug remains approved, with restrictions, appeals court rules

Mifepristone will remain on the market, but approved only for use up to seven weeks of pregnancy, versus 10 weeks, and it cannot be prescribed by telehealth or mailed, which were already illegal in Texas.

The Texas Tribune

U.S. appeals court preserves partial access to abortion pill, but with tighter rules

The Biden administration had asked the higher court to stay a decision from a Texas judge while the appeal plays out.

WEKU

Appeals court keeps abortion drug on the market, with some limits - Roll Call

A federal appeals court allowed the nation’s most-used medication abortion drug to remain on the market after Saturday.

Roll Call

US abortion pill providers see surge in interest after judge targets mifepristone

People are seeking the advance provision of medication before Friday’s deadline, when the drug may become unavailable

The Guardian - US

Texas abortion pill ruling partly blocked by appeals court – but barriers to access upheld

An appeals court ruling prevents an outright ban on mifepristone, but the conservative panel has effectively made the drug harder for millions of Americans to obtain

The Independent UK

Robin Abcarian: Hang on to the pill and your IUD. After abortion, birth control is the next fight

Mark my words: Contraception is the next front in the war on women. And we can't say we haven't been warned.

Los Angeles Times

Get all your
news in one place.

100's of premium titles.
One news app.

St. Louis Post-Dispatch

Editorial: Judge had a basis for his attack on FDA, but not regarding mifepristone

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

WEKU

Federal appeals court preserves access to abortion drug but with tighter rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail.

The Independent UK

Court preserves access to abortion drug, tightens rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail

Marie Claire

"I never took Ozempic with weight loss in mind - but it's totally changed my life."

Three women share their honest experiences taking the controversial diabetes drug.

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

Federal appeals court partially blocks Texas abortion pill ruling

The ruling means mifepristone is still available in the U.S., but with several strict limitations.

Tribune News Service

Feds launch criminal investigation into ‘AGGA’ dental device and its inventor

Federal prosecutors have launched a criminal investigation into the Anterior Growth Guidance Appliance, or “AGGA” dental device, following a recent KFF Health News-CBS News investigation, according to a motion filed in federal court.

Chicago Sun-Times

Juul to pay Illinois $67.6 million as part of multi-state settlement in vaping lawsuit

The e-cigarette manufacturer will pay $462 million in all to settle the lawsuit, which alleges the company marketed to minors and misled consumers about health risks.

Tribune News Service

Members of Congress weigh in on court fight over abortion drug

WASHINGTON — A Louisiana-based federal appeals court could decide as soon as Wednesday the availability of the nation’s most used medication abortion drug, as members of Congress from both parties weighed in on a lower court ruling that would stop the manufacture and distribution of the drug this Saturday.

The Independent UK

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

Axios

What to know about the Comstock Act as abortion pill fight escalates

Anti-abortion groups have revived the centuries-old law.

Al Jazeera

White House vows to fight for abortion pills, patient privacy

Moves follow Texas ruling suspending federal approval for abortion pills, state efforts to restrict travel for abortion.

1 … 157 158 159 160

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

348 stories

APA

271 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.